Transplantation of alginate microcapsules: generation of antibodies against alginates and encapsulated porcine islet-like cell clusters.

BACKGROUND Microencapsulation of islets of Langherhans in alginate poly-L-lysine capsules provides an effective protection against cell-mediated immune destruction, and ideally should allow the transplantation of islets in the absence of immunosuppression. It has previously been suggested that alginate rich in mannuronic acid (high M) is more immunogenic than alginate rich in guluronic acid (high G). The ability of these alginates to induce an antibody response in the recipient or act as an adjuvant to antibody responses against antigens leaked from the capsule was investigated in the present study. METHODS Empty capsules made from these different types of alginate were transplanted intraperitoneally to Wistar rats or Balb/c mice. In addition, some animals were also injected with bovine serum albumin to assess the ability of the alginates to act as an adjuvant to this antigen. Antibody responses to intraperitoneally transplanted free and microencapsulated fetal porcine islet like cell clusters (ICC) were also evaluated, in animals treated with or without cyclosporine. RESULTS Antibodies against high M-alginate capsules were detected in the sera of mice transplanted with this capsule type. However, this response was not seen after the transplantation of high G capsules. When Wistar rats were used as recipients, no antibody responses were detected against any type of alginate capsules. Neither type of capsule acted as an adjuvant. Antibodies against ICC were present, in rats transplanted with both nonencapsulated and encapsulated ICCs. Administration of cyclosporine could abolish this production of antibodies against ICC. CONCLUSIONS High G-alginate capsules are less immunogenic than high M capsules. Because encapsulation did not protect against the generation of antibodies against ICC, it can be assumed that antigen leakage from the capsules occurs, as no evidence was found for capsules breaking in vivo.

[1]  Y. Liu,et al.  Is CTLA-4 a negative regulator for T-cell activation? , 1997, Immunology today.

[2]  P. Linsley,et al.  CTLA4-Ig prolongs survival of microencapsulated neonatal porcine islet xenografts in diabetic NOD mice. , 1997, Cell transplantation.

[3]  B. Kulseng,et al.  Alginate polylysine microcapsules as immune barrier: permeability of cytokines and immunoglobulins over the capsule membrane. , 1997, Cell transplantation.

[4]  G. Skjåk-Bræk,et al.  Induction of tumor necrosis factor production from monocytes stimulated with mannuronic acid polymers and involvement of lipopolysaccharide-binding protein, CD14, and bactericidal/permeability-increasing factor , 1997, Infection and immunity.

[5]  A. Sun,et al.  Normalization of diabetes in spontaneously diabetic cynomologus monkeys by xenografts of microencapsulated porcine islets without immunosuppression. , 1996, The Journal of clinical investigation.

[6]  P. Bruheim,et al.  Alginate polycation microcapsules. II. Some functional properties. , 1996, Biomaterials.

[7]  D. Ecker,et al.  A simple method for xenotransplanting cells and tissues into rats using uncoated alginate microreactors. , 1996, Transplantation proceedings.

[8]  B. Kulseng,et al.  TNF Production from Peripheral Blood Mononuclear Cells in Diabetic Patients after Stimulation with Alginate and Lipopolysaccharide , 1996, Scandinavian journal of immunology.

[9]  T. Espevik,et al.  An immunosuppressive murine leukaemia virus induces a Th1 → Th2 switch and abrogates the IgM antibody response to sheep erythrocytes by suppressing the production of IL‐2 , 1995, Clinical and experimental immunology.

[10]  T. Mohanakumar,et al.  Analysis of the serological and cellular sensitization induced by encapsulated human islets transplantation in type I and type II diabetes patients. , 1995, Cell transplantation.

[11]  R. Lanza,et al.  Xenogenic humoral responses to islets transplanted in biohybrid diffusion chambers. , 1994, Transplantation.

[12]  J. Lötvall,et al.  Treatment with cyclosporin A during sensitization with trimellitic anhydride attenuates the airway responses to allergen challenge three weeks later. , 1994, European journal of pharmacology.

[13]  C. J. van Oss,et al.  The adjuvant effect of silicone-gel on antibody formation in rats. , 1993, Immunological investigations.

[14]  G. Skjåk‐Braek,et al.  The involvement of CD14 in stimulation of cytokine production by uronic acid polymers , 1993, European journal of immunology.

[15]  Patrick Soon-Shiong,et al.  Induction of Cytokine Production from Human Monocytes Stimulated with Alginate , 1991, Journal of immunotherapy : official journal of the Society for Biological Therapy.

[16]  G. Skjåk-Bræk,et al.  Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads , 1989, Biotechnology and bioengineering.

[17]  O. Korsgren,et al.  LARGE‐SCALE PRODUCTION OF FETAL PORCINE PANCREATIC ISLETLIKE CELL CLUSTERS: An Experimental Tool for Studies of Islet Cell Differentiation and Xenotransplantation , 1988, Transplantation.

[18]  G. Skjåk‐Braek,et al.  Monomer sequence and acetylation pattern in some bacterial alginates. , 1986, Carbohydrate research.

[19]  H. Grasdalen High-field, 1H-n.m.r. spectroscopy of alginate: sequential structure and linkage conformations , 1983 .

[20]  C. Wilson,et al.  Quantitation of acute and chronic serum sickness in the rabbit. , 1971, The Journal of experimental medicine.

[21]  A. Cunningham,et al.  Further improvements in the plaque technique for detecting single antibody-forming cells. , 1968, Immunology.

[22]  P. Bruheim,et al.  Alginate polycation microcapsules. I. Interaction between alginate and polycation. , 1996, Biomaterials.

[23]  D. Ecker,et al.  Xenotransplantation of porcine and bovine islets without immunosuppression using uncoated alginate microspheres. , 1995, Transplantation.

[24]  G. Skjåk-Bræk,et al.  Comparison of different methods for determination of molecular weight and molecular weight distribution of alginates , 1991 .

[25]  M. Goosen,et al.  Injectable microencapsulated islet cells as a bioartificial pancreas , 1984, Applied biochemistry and biotechnology.

[26]  A. Theofilopoulos,et al.  The biology and detection of immune complexes. , 1979, Advances in immunology.